PAVmed, Inc. (PAVM)

5.33 +0.23 (+4.51%) USD  |  NASDAQ  |  Aug 25, 15:57
More

PAVmed Revenue Estimates for Next Fiscal Year

Revenue Estimates for Next Fiscal Year Chart

View Revenue Estimates for Next Fiscal Year for PAVM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Next Fiscal Year Chart
Start Trial

Historical Revenue Estimates for Next Fiscal Year Data

View and export this data back to 2023. Start Trial.
Date Value
August 14, 2026 --
June 06, 2026 --
May 18, 2026 --
April 09, 2026 --
March 31, 2026 --
December 10, 2025 --
October 04, 2025 --
August 15, 2025 --
June 06, 2025 --
May 15, 2025 --
April 21, 2025 --
April 04, 2025 --
March 26, 2025 --
December 09, 2024 --
November 15, 2024 --
September 24, 2024 --
Date Value
September 10, 2024 --
August 14, 2024 --
August 13, 2024 --
April 14, 2024 --
March 28, 2024 --
March 27, 2024 --
December 09, 2023 --
November 16, 2023 --
November 15, 2023 --
September 06, 2023 --
August 17, 2023 --
May 18, 2023 --
April 10, 2023 --
March 15, 2023 --
January 20, 2023 --
January 18, 2023 --

Revenue Estimates for Next Fiscal Year Range, Past 5 Years

View Revenue Estimates for Next Fiscal Year Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Next Fiscal Year Benchmarks

View Revenue Estimates for Next Fiscal Year Benchmarks
Start Trial
Abbott Laboratories Upgrade
AngioDynamics, Inc. Upgrade
Alphatec Holdings, Inc. Upgrade
AtriCure, Inc. Upgrade
Baxter International, Inc. Upgrade

Revenue Estimates for Next Fiscal Year Related Metrics

Revenue Estimates for Current Quarter Upgrade
Revenue Estimates for Next Quarter Upgrade
Revenue Estimates for Current Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade